About the Company
novel therapeutics for metabolic and endocrine disorders.
Please visit http://www.vikingtherapeutics.com for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VKTX News
Viking Therapeutics takes advantage of soaring stock price to issue fresh shares at a discount
Viking Therapeutics Inc., the clinical-stage biotech that wowed investors this week with promising data from a mid-stage ...
Viking Therapeutics faces higher bar for oral weight-loss drug after strong readout from rival
Viking Therapeutics Inc.’s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an ...
What's Going On With Viking Therapeutics (VKTX) Stock?
Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading lower by 10.9% to $63.95 Monday afternoon, despite a lack of company ...
Buy Rating Affirmed for Viking Therapeutics: Promising NASH Treatments and Competitive Edge in Metabolic Disease Pipeline
Begin your TipRanks Premium journey today. Viking Therapeutics (VKTX) Company Description: Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ...
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
Lilly's drugs, like the Viking candidate, act on two hormone pathways that control blood sugar levels and appetite -- ...
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
Viking Therapeutics ( VKTX 3.73%) announced results last week from a phase 2 clinical study of VK2735 in helping patients ...
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Electrocore (ECOR – Research Report) and ...
Viking Therapeutics’ stock more than doubles as investors cheer cheap entry to weight-loss-drug craze
Viking Therapeutics Inc.’s stock soared 121% Tuesday to close at a record high, after the company announced positive results from a Phase 2 trial of its weight-loss drug VK2735, a GLP-1 receptor ...
Viking Therapeutics Inc VKTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Viking Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...